查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1371973

2030 年生物材料市場預測：按類型、應用和地區分類的全球分析

Biomaterials Market Forecasts to 2030 - Global Analysis By Type, By Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據，2023年全球生物材料市場規模為1,801億美元，預計2030年將達到5,153億美元，預測期內年複合成長率為16.2%。

生物材料是專為醫療和保健應用而設計的專用材料，可與生物系統相互作用，以幫助診斷、治療和組織修復。這些材料被設計為具有生物相容性，可以與身體無縫整合，不會造成傷害或副作用。生物材料包括多種材料，包括金屬、聚合物、陶瓷和複合材料，並用於各種醫療設備、植入物、藥物傳輸系統和組織工程。

根據世界衛生組織 (WHO) 2022 年 3 月的更新，恆牙齲齒影響全球估計 20 億人，乳牙齲齒年度影響 5.2 億兒童。

對植入設備的需求增加

隨著社會不斷高齡化，對整形外科植入物、心血管支架等醫療設備的需求也不斷增加。生物材料在提高這些設備的生物相容性和使用壽命方面發揮著至關重要的作用。此外，微創手術技術的進步正在擴大植入式醫療設備的範圍並提高普及。由於需要手術介入的慢性疾病盛行率不斷上升，對生物材料的需求進一步增加。因此，生物材料市場持續擴大，因為植入式醫療設備在改善患者生活品質方面發揮關鍵作用。

嚴格的臨床和法規流程

醫用生物材料的開發和商業化需要廣泛的臨床試驗並遵守嚴格的法規指南，導致研究上市時間較長和大量投資。這將會是。這些確保安全性和有效性的流程可以防止小型企業因高昂的合規成本而進入市場。此外，法規障礙可能會導致現有生物材料製造商的延誤和成本增加。雖然對病人安全至關重要，但這些嚴格的要求限制了創新和市場進入的速度，阻礙了新型生物材料快速引入醫療保健領域。

新興國家醫療保健市場的成長

隨著醫療保健服務的改善和可支配所得的增加，這些地區對先進醫療方法和醫療設備（包括依賴生物材料的設備）的需求正在迅速增加。隨著醫療保健基礎設施的擴大，整形外科、心血管治療和組織工程對生物材料的需求不斷增加。這為生物材料製造商提供了一個巨大的市場，可以滿足未滿足的醫療需求，促進研究合作，並提供適合這些新興國家醫療保健系統需求的經濟高效的解決方案。這使得生物材料公司能夠開拓新市場並幫助改善新興國家的醫療保健。

缺乏熟練的外科醫生

熟練的手術技術和實踐對於生物材料的成功應用至關重要。然而，缺乏訓練有素、經驗豐富的外科醫生可能會阻礙生物材料在從移植到組織工程等各種醫療手術中的有效利用。這種限制可能導致患者預後不佳、併發症、效率低下，並影響生物材料在醫療保健領域的聲譽。應對這一威脅需要對醫學教育和培訓計劃進行投資，以確保有足夠數量的熟練外科醫生具備使用生物材料的能力，使他們能夠最大限度地發揮潛力並改善患者照護。

COVID-19 的影響：

COVID-19大流行對生物材料產業產生了重大影響。一方面，由於對人工呼吸器、個人防護設備（PPE）和診斷工具等醫療用品和設備的迫切需求，對生物材料的需求激增。生物材料在這些醫療保健必需品的開發和製造中發揮了重要作用。同時，疫情擾亂了全球供應鏈，導致生物材料的生產和分銷延遲。生物材料領域的臨床試驗和研究項目也受到影響。隨著世界各地努力應對這場流行病，業界的應對措施是優先考慮用於疫苗開發和診斷的生物材料研究，進一步凸顯了該領域對公共衛生的重要性。

金屬基生物材料產業預計將在預測期內成為最大的產業

金屬基生物材料在生物材料市場中佔有很大佔有率。這些材料具有高強度、耐用性和耐腐蝕，使其成為整形外科植入物（例如人工關節和牙科用裝置）和心血管支架等應用的理想選擇。金屬生物材料通常由鈦和不銹鋼等材料製成，具有優異的機械性能，可確保人體內的壽命和穩定性。在提供強大的結構支援的同時，在其設計和開發中考慮生物相容性和減少潛在的過敏反應至關重要，這使得金屬生物材料成為醫療治療和手術進步的關鍵推動者。您可以做出巨大的貢獻。

整形外科預計在預測期內年複合成長率最高

在預測期內，生物材料市場年複合成長率最高的是整形外科領域。金屬、聚合物、陶瓷和複合材料等生物材料經過精心設計，可替換或修復受損或退化的骨骼、關節和韌帶。它廣泛用於各種整形外科器械，包括人工關節（例如髖關節和膝關節）、接骨板和螺絲。生物相容性、機械強度和耐磨性是整形外科生物材料的重要特性，可確保植入物的使用壽命和有效性。整形外科生物材料的進步顯著改善了整形外科疾病患者的生活品質，並已成為整形外科護理的重要組成部分。

比最大的地區

北美佔據重要地位，預計在預測期內將佔據最大佔有率。該地區在醫療和牙科領域擁有強大的影響力，推動了對各種應用的生物材料的需求，包括整形外科、心血管和人工植牙。此外，對技術進步的重視以及對生物材料優勢的認知不斷提高也推動了創新和市場成長。嚴格的法規準則也有助於產品品質和安全。北美仍然是全球生物材料市場的主要企業，重點關注醫療進步和改善患者治療結果。

複合年複合成長率最高的地區：

由於醫療保健部門的快速擴張、研發投資的增加以及老年人口的不斷成長，亞太地區的生物材料市場年複合成長率最高。該地區慢性病盛行率不斷上升，加上中階人口不斷成長，正在推動整形外科、心血管和創傷治療等應用領域對生物材料的需求。此外，先進醫療技術的採用和醫療保健成本的上升正在推動生物材料在創新醫療設備和植入物中的使用。亞太地區對全球生物材料市場做出了重大貢獻，為國內外生物材料公司提供了巨大的成長潛力和機會。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場公司的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的競爭關係

第5章 全球生物材料市場：依類型

  • 金屬生物材料
    • 不銹鋼
    • 鈦及鈦合金
    • 鈷鉻合金
    • 錢
    • 銀
    • 鎂
  • 高分子生物材料
    • 聚甲基丙烯酸甲酯
    • 聚乙烯
    • 聚酯纖維
    • 矽橡膠
    • 尼龍
    • 聚醚醚酮
    • 其他高分子生物材料
  • 陶瓷
    • 磷酸鈣
    • 氧化鋯
    • 氧化鋁
    • 硫酸鈣
    • 碳
    • 玻璃
  • 天然生物材料
    • 玻尿酸
    • 膠原
    • 明膠
    • 纖維蛋白
    • 纖維素
    • 廚房
    • 藻酸鹽
    • 絲綢

第6章 全球生物材料市場：依應用分類

  • 心血管
    • 支架
    • 植入式心臟整流去顫器
    • 起搏器
    • 心臟瓣膜
    • 血管移植物
  • 整形外科
    • 關節重建手術
      • 關節重建
      • 髖關節置換術
      • 肩關節置換術
    • 關節內粘稠補充療法
    • 生物可吸收組織的固定
      • 縫合錨釘
      • 緊固螺絲
      • 半月軟骨修復螺柱
      • 網
    • 脊椎
      • 脊椎融合手術
      • 微創融合手術
      • 運動保留手術及動態穩定化手術
    • 骨折固定裝置
      • 骨板
      • 擰緊
      • 別針
      • 桿
      • 金屬絲
    • 合成骨移植物
  • 眼科
    • 隱形眼鏡
      • 人工水晶體
      • 眼組織的功能性替代
      • 人工角膜
  • 牙科
    • 人工植牙
    • 牙科骨移植片和替代
    • 牙膜
    • 組織再生
  • 整形外科
    • 軟組織填充劑
    • 顱顏手術
  • 創傷治療
    • 傷口縫合裝置
    • 手術止血器
    • 內部組織密封膠
    • 黏附屏障
    • 疝氣網
  • 人體組織工程
    • 再生醫學支架
    • 生物感
    • 無機奈米粒子的製備
  • 神經系統/中樞神經系統的應用
    • 分流系統
    • 皮質神經假體
    • 用於中樞神經系統修復的水凝膠支架
    • 神經幹細胞封裝
  • 其他用途
    • 藥物輸送系統
    • 胃腸道應用
    • 減重手術
    • 泌尿系統的應用

第7章 全球生物材料市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第8章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第9章 公司簡介

  • Corbion NV
  • Royal DSM
  • Noble Biomaterials Inc.
  • Covalon Technologies Ltd.
  • Zimmer Biomet Holdings, Inc.
  • Linden Capital Partners（Collagen Matrix, Inc.）
  • Stryker Corporation（Wright Medical Group NV）
  • Victrex Plc
  • Evonik Industries
  • Carpenter Technology Corporation
  • Medtronic plc
  • Berkeley Advanced Biomaterials
Product Code: SMRC24029

According to Stratistics MRC, the Global Biomaterials Market is accounted for $180.1 billion in 2023 and is expected to reach $515.3 billion by 2030 growing at a CAGR of 16.2% during the forecast period. Biomaterials are specialized materials designed for use in medical and healthcare applications, where they interact with biological systems to aid in diagnostics, treatment, or tissue repair. These materials are engineered to be biocompatible, meaning they can integrate seamlessly with the body without causing harm or adverse reactions. Biomaterials encompass a wide range of substances, including metals, polymers, ceramics, and composites, and are used in various medical devices, implants, drug delivery systems, and tissue engineering.

According to the March 2022 update of the World Health Organization, caries of permanent teeth affect an estimated 2 billion individuals worldwide, while caries of primary teeth affect 520 million children annually.

Market Dynamics:

Driver:

Increasing demand for implantable devices

As the aging population grows, so does the need for medical devices like orthopedic implants and cardiovascular stents. Biomaterials play a pivotal role in enhancing the biocompatibility and longevity of these devices. Moreover, advancements in minimally invasive surgical techniques have expanded the range of implantable medical devices, increasing their prevalence. The demand for biomaterials is further driven by the rising incidence of chronic diseases that require surgical interventions. As a result, the biomaterials market continues to expand, driven by the critical role it plays in improving the quality of life for patients requiring implantable medical devices.

Restraint:

Stringent clinical & regulatory processes

The development and commercialization of biomaterials for medical applications require extensive clinical testing and adherence to stringent regulatory guidelines, leading to prolonged research-to-market timelines and significant financial investments. These processes, intended to ensure safety and efficacy, can deter smaller companies from entering the market due to high compliance costs. Additionally, regulatory hurdles may result in delays and increased expenses for established biomaterial manufacturers. While essential for patient safety, these strict requirements limit the speed of innovation and market entry, thereby hindering the rapid introduction of novel biomaterials into the healthcare sector.

Opportunity:

Growing healthcare market in emerging economies

With improving access to healthcare and rising disposable incomes, these regions are witnessing a surge in demand for advanced medical treatments and devices, including those reliant on biomaterials. As healthcare infrastructure expands the need for biomaterials in orthopedics, cardiovascular treatments, and tissue engineering rises. This offers a substantial market for biomaterial manufacturers to address unmet medical needs, foster research collaborations, and provide cost-effective solutions tailored to the demands of these developing healthcare systems. It positions biomaterial companies to tap into new markets and contribute to enhanced medical care in emerging economies.

Threat:

Shortage of skilled surgeons

The successful application of biomaterials often relies on proficient surgical techniques and practices. However, a shortage of well-trained and experienced surgeons can hinder the effective utilization of biomaterials in various medical procedures, from implantations to tissue engineering. This limitation may lead to suboptimal patient outcomes, complications, and inefficiencies, affecting the reputation of biomaterials in healthcare. Addressing this threat requires investments in medical education and training programs to ensure that an adequate number of skilled surgeons are available to work with biomaterials, maximizing their potential and expanding their positive impact in patient care.

COVID-19 Impact:

The COVID-19 pandemic has had a notable impact on the biomaterials industry. On one hand, the demand for biomaterials surged in response to the urgent need for medical supplies and equipment, such as ventilators, personal protective equipment (PPE), and diagnostic tools. Biomaterials played a critical role in developing and manufacturing these healthcare essentials. On the other hand, the pandemic disrupted global supply chains, leading to delays in production and distribution of biomaterials. Clinical trials and research projects in the biomaterials sector were also affected. As the world grappled with the pandemic, the industry adapted by prioritizing research on biomaterials for vaccine development and diagnostics, further highlighting the sector's importance in public health.

The metallic biomaterials segment is expected to be the largest during the forecast period

The metallic biomaterials have a significant share in the Biomaterials market. These materials exhibit high strength, durability, and corrosion resistance, making them ideal for applications like orthopedic implants (e.g., joint replacements and dental fixtures) and cardiovascular stents. Metallic biomaterials, often made of materials such as titanium and stainless steel, offer excellent mechanical properties, ensuring longevity and stability within the human body. While they provide robust structural support, considerations for biocompatibility and the reduction of potential allergic reactions are essential in their design and development, allowing metallic biomaterials to contribute significantly to the advancement of medical treatments and procedures.

The orthopaedic segment is expected to have the highest CAGR during the forecast period

The orthopaedic has the highest CAGR within the Biomaterials market over the forecast period. These biomaterials, such as metals, polymers, ceramics, and composites, are carefully engineered to replace or repair damaged or degenerated bones, joints, and ligaments. They are employed in a wide range of orthopedic devices, including artificial joints (such as hip and knee replacements), bone plates, and screws. Biocompatibility, mechanical strength, and wear resistance are key attributes in orthopedic biomaterials to ensure the longevity and effectiveness of implants. Advancements in orthopedic biomaterials have significantly improved the quality of life for patients with orthopedic conditions, making them a vital component of orthopedic medicine.

Region with largest share:

North America holds a significant position and expected to hold a largest share over the forecast period. The region's robust presence in the medical and dental fields drives the demand for biomaterials used in various applications, such as orthopedics, cardiovascular, and dental implants. Furthermore, an emphasis on technological advancements, coupled with increasing awareness of the benefits of biomaterials, fuels innovation and market growth. Stringent regulatory guidelines also contribute to product quality and safety. North America continues to be a key player in the global biomaterials market, with a strong focus on medical advancements and improving patient outcomes.

Region with highest CAGR:

The Asia-Pacific region witnessed the highest CAGR in the Biomaterials market, driven by its rapidly expanding healthcare sector, increasing investments in research and development, and a growing geriatric population. The region's rising incidence of chronic diseases, coupled with a burgeoning middle-class population, fuels the demand for biomaterials in applications like orthopedics, cardiovascular, and wound healing. Additionally, the adoption of advanced medical technologies and increasing healthcare expenditure drive the use of biomaterials for innovative medical devices and implants. Asia-Pacific as a significant contributor to the global biomaterials market, with substantial growth potential and opportunities for both domestic and international biomaterial companies.

Key players in the market:

Some of the key players in Biomaterials Market include: Corbion N.V, Royal DSM, Noble Biomaterials Inc., Covalon Technologies Ltd., Zimmer Biomet Holdings, Inc., Stryker Corporation (Wright Medical Group N.V), Victrex Plc, Evonik Industries, Carpenter Technology Corporation, Medtronic plc, Berkeley Advanced Biomaterials and Collagen Matrix.

Key Developments:

In June 2023, Covation Biomaterials, a worldwide provider of bio-based solutions, emerged as an independent business after the Huafon Group acquired DuPont Biomaterials.

In December 2022, Orthopedics Inc., and Invibio Biomaterial Solutions made an announcement of the successful initiation of the study and implantation for the total knee arthroplasty (TKA) on the very first patients with the new polymer, PEEK-OPTIMA™ femoral knee component. This component offers surgeons and patients a femoral component that has the ability to correct component to bone material mismatch.

In May 2022, DuPont announced the launch of a new spun yarn collection in collaboration with JP Modatex India, blending natural fibers with DuPont Sorona staple fibers. The collection combines linen and partially plant-based Sorona fibers to create spun yarns suitable for various applications, such as dresses, shirting, pants and skirts, denim, and jackets.

Types Covered:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramics
  • Natural Biomaterials

Applications Covered:

  • Cardiovascular
  • Orthopaedic
  • Ophthalmology
  • Dental
  • Plastic Surgery
  • Wound Healing
  • Tissue Engineering
  • Neurological/Central Nervous System Applications
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Application Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Biomaterials Market, By Type

  • 5.1 Introduction
  • 5.2 Metallic Biomaterials
    • 5.2.1 Stainless Steel
    • 5.2.2 Titanium & Titanium Alloys
    • 5.2.3 Cobalt-Chrome Alloys
    • 5.2.4 Gold
    • 5.2.5 Silver
    • 5.2.6 Magnesium
  • 5.3 Polymeric Biomaterials
    • 5.3.1 Polymethylmethacrylate
    • 5.3.2 Polyethylene
    • 5.3.3 Polyester
    • 5.3.4 Silicone Rubber
    • 5.3.5 Nylon
    • 5.3.6 Polyetheretherketone
    • 5.3.7 Other Polymeric Biomaterials
  • 5.4 Ceramics
    • 5.4.1 Calcium Phosphate
    • 5.4.2 Zirconia
    • 5.4.3 Aluminum Oxide
    • 5.4.4 Calcium Sulfate
    • 5.4.5 Carbon
    • 5.4.6 Glass
  • 5.5 Natural Biomaterials
    • 5.5.1 Hyaluronic Acid
    • 5.5.2 Collagen
    • 5.5.3 Gelatin
    • 5.5.4 Fibrin
    • 5.5.5 Cellulose
    • 5.5.6 Chitin
    • 5.5.7 Alginates
    • 5.5.8 Silk

6 Global Biomaterials Market, By Application

  • 6.1 Introduction
  • 6.2 Cardiovascular
    • 6.2.1 Stents
    • 6.2.2 Implantable Cardiac Defibrillators
    • 6.2.3 Pacemakers
    • 6.2.4 Heart Valves
    • 6.2.5 Vascular Grafts
  • 6.3 Orthopaedic
    • 6.3.1 Joint Replacement
      • 6.3.1.1 Knee Replacement
      • 6.3.1.2 Hip Replacement
      • 6.3.1.3 Shoulder Replacement
    • 6.3.2 Viscosupplementation
    • 6.3.3 Bioresorbable Tissue Fixation
      • 6.3.3.1 Suture Anchors
      • 6.3.3.2 Interference Screws
      • 6.3.3.3 Meniscal Repair Tacks
      • 6.3.3.4 Meshes
    • 6.3.4 Spine
      • 6.3.4.1 Spinal Fusion Surgeries
      • 6.3.4.2 Minimally Invasive Fusion Surgeries
      • 6.3.4.3 Motion Preservation & Dynamic Stabilization Surgeries
    • 6.3.5 Fracture Fixation Devices
      • 6.3.5.1 Bone Plates
      • 6.3.5.2 Screws
      • 6.3.5.3 Pins
      • 6.3.5.4 Rods
      • 6.3.5.5 Wires
    • 6.3.6 Synthetics Bone Grafts
  • 6.4 Ophthalmology
    • 6.4.1 Contact Lenses
      • 6.4.1.1 Intraocular Lenses
      • 6.4.1.2 Functional Replacement of Ocular Tissues
      • 6.4.1.3 Synthetic Corneas
  • 6.5 Dental
    • 6.5.1 Dental Implants
    • 6.5.2 Dental Bone Grafts & Substitutes
    • 6.5.3 Dental Membranes
    • 6.5.4 Tissue Regeneration
  • 6.5 Plastic Surgery
    • 6.5.1 Soft-Tissue Fillers
    • 6.5.2 Craniofacial Surgery
  • 6.6 Wound Healing
    • 6.6.1 Wound Closure Devices
    • 6.6.2 Surgical Hemostats
    • 6.6.3 Internal Tissue Sealants
    • 6.6.4 Adhesion Barriers
    • 6.6.5 Hernia Meshes
  • 6.7 Tissue Engineering
    • 6.7.1 Scaffolds for Regenerative Medicine
    • 6.7.2 Biosensing
    • 6.7.3 Tailoring of Inorganic Nanoparticles
  • 6.8 Neurological/Central Nervous System Applications
    • 6.8.1 Shunting Systems
    • 6.8.2 Cortical Neural Prosthetics
    • 6.8.3 Hydrogel Scaffolds for CNS Repair
    • 6.8.4 Neural Stem Cell Encapsulation
  • 6.9 Other Applications
    • 6.9.1 Drug Delivery Systems
    • 6.9.2 Gastrointestinal Applications
    • 6.9.3 Bariatric Surgery
    • 6.9.4 Urinary Applications

7 Global Biomaterials Market, By Geography

  • 7.1 Introduction
  • 7.2 North America
    • 7.2.1 US
    • 7.2.2 Canada
    • 7.2.3 Mexico
  • 7.3 Europe
    • 7.3.1 Germany
    • 7.3.2 UK
    • 7.3.3 Italy
    • 7.3.4 France
    • 7.3.5 Spain
    • 7.3.6 Rest of Europe
  • 7.4 Asia Pacific
    • 7.4.1 Japan
    • 7.4.2 China
    • 7.4.3 India
    • 7.4.4 Australia
    • 7.4.5 New Zealand
    • 7.4.6 South Korea
    • 7.4.7 Rest of Asia Pacific
  • 7.5 South America
    • 7.5.1 Argentina
    • 7.5.2 Brazil
    • 7.5.3 Chile
    • 7.5.4 Rest of South America
  • 7.6 Middle East & Africa
    • 7.6.1 Saudi Arabia
    • 7.6.2 UAE
    • 7.6.3 Qatar
    • 7.6.4 South Africa
    • 7.6.5 Rest of Middle East & Africa

8 Key Developments

  • 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 8.2 Acquisitions & Mergers
  • 8.3 New Product Launch
  • 8.4 Expansions
  • 8.5 Other Key Strategies

9 Company Profiling

  • 9.1 Corbion N.V
  • 9.2 Royal DSM
  • 9.3 Noble Biomaterials Inc.
  • 9.4 Covalon Technologies Ltd.
  • 9.5 Zimmer Biomet Holdings, Inc.
  • 9.6 Linden Capital Partners (Collagen Matrix, Inc.)
  • 9.7 Stryker Corporation (Wright Medical Group N.V)
  • 9.8 Victrex Plc
  • 9.9 Evonik Industries
  • 9.10 Carpenter Technology Corporation
  • 9.11 Medtronic plc
  • 9.12 Berkeley Advanced Biomaterials

List of Tables

  • Table 1 Global Biomaterials Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Biomaterials Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Biomaterials Market Outlook, By Metallic Biomaterials (2021-2030) ($MN)
  • Table 4 Global Biomaterials Market Outlook, By Stainless Steel (2021-2030) ($MN)
  • Table 5 Global Biomaterials Market Outlook, By Titanium & Titanium Alloys (2021-2030) ($MN)
  • Table 6 Global Biomaterials Market Outlook, By Cobalt-Chrome Alloys (2021-2030) ($MN)
  • Table 7 Global Biomaterials Market Outlook, By Gold (2021-2030) ($MN)
  • Table 8 Global Biomaterials Market Outlook, By Silver (2021-2030) ($MN)
  • Table 9 Global Biomaterials Market Outlook, By Magnesium (2021-2030) ($MN)
  • Table 10 Global Biomaterials Market Outlook, By Polymeric Biomaterials (2021-2030) ($MN)
  • Table 11 Global Biomaterials Market Outlook, By Polymethylmethacrylate (2021-2030) ($MN)
  • Table 12 Global Biomaterials Market Outlook, By Polyethylene (2021-2030) ($MN)
  • Table 13 Global Biomaterials Market Outlook, By Polyester (2021-2030) ($MN)
  • Table 14 Global Biomaterials Market Outlook, By Silicone Rubber (2021-2030) ($MN)
  • Table 15 Global Biomaterials Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 16 Global Biomaterials Market Outlook, By Polyetheretherketone (2021-2030) ($MN)
  • Table 17 Global Biomaterials Market Outlook, By Other Polymeric Biomaterials (2021-2030) ($MN)
  • Table 18 Global Biomaterials Market Outlook, By Ceramics (2021-2030) ($MN)
  • Table 19 Global Biomaterials Market Outlook, By Calcium Phosphate (2021-2030) ($MN)
  • Table 20 Global Biomaterials Market Outlook, By Zirconia (2021-2030) ($MN)
  • Table 21 Global Biomaterials Market Outlook, By Aluminum Oxide (2021-2030) ($MN)
  • Table 22 Global Biomaterials Market Outlook, By Calcium Sulfate (2021-2030) ($MN)
  • Table 23 Global Biomaterials Market Outlook, By Carbon (2021-2030) ($MN)
  • Table 24 Global Biomaterials Market Outlook, By Glass (2021-2030) ($MN)
  • Table 25 Global Biomaterials Market Outlook, By Natural Biomaterials (2021-2030) ($MN)
  • Table 26 Global Biomaterials Market Outlook, By Hyaluronic Acid (2021-2030) ($MN)
  • Table 27 Global Biomaterials Market Outlook, By Collagen (2021-2030) ($MN)
  • Table 28 Global Biomaterials Market Outlook, By Gelatin (2021-2030) ($MN)
  • Table 29 Global Biomaterials Market Outlook, By Fibrin (2021-2030) ($MN)
  • Table 30 Global Biomaterials Market Outlook, By Cellulose (2021-2030) ($MN)
  • Table 31 Global Biomaterials Market Outlook, By Chitin (2021-2030) ($MN)
  • Table 32 Global Biomaterials Market Outlook, By Alginates (2021-2030) ($MN)
  • Table 33 Global Biomaterials Market Outlook, By Silk (2021-2030) ($MN)
  • Table 34 Global Biomaterials Market Outlook, By Application (2021-2030) ($MN)
  • Table 35 Global Biomaterials Market Outlook, By Cardiovascular (2021-2030) ($MN)
  • Table 36 Global Biomaterials Market Outlook, By Stents (2021-2030) ($MN)
  • Table 37 Global Biomaterials Market Outlook, By Implantable Cardiac Defibrillators (2021-2030) ($MN)
  • Table 38 Global Biomaterials Market Outlook, By Pacemakers (2021-2030) ($MN)
  • Table 39 Global Biomaterials Market Outlook, By Heart Valves (2021-2030) ($MN)
  • Table 40 Global Biomaterials Market Outlook, By Vascular Grafts (2021-2030) ($MN)
  • Table 41 Global Biomaterials Market Outlook, By Orthopaedic (2021-2030) ($MN)
  • Table 42 Global Biomaterials Market Outlook, By Joint Replacement (2021-2030) ($MN)
  • Table 43 Global Biomaterials Market Outlook, By Knee Replacement (2021-2030) ($MN)
  • Table 44 Global Biomaterials Market Outlook, By Hip Replacement (2021-2030) ($MN)
  • Table 45 Global Biomaterials Market Outlook, By Shoulder Replacement (2021-2030) ($MN)
  • Table 46 Global Biomaterials Market Outlook, By Viscosupplementation (2021-2030) ($MN)
  • Table 47 Global Biomaterials Market Outlook, By Bioresorbable Tissue Fixation (2021-2030) ($MN)
  • Table 48 Global Biomaterials Market Outlook, By Suture Anchors (2021-2030) ($MN)
  • Table 49 Global Biomaterials Market Outlook, By Interference Screws (2021-2030) ($MN)
  • Table 50 Global Biomaterials Market Outlook, By Meniscal Repair Tacks (2021-2030) ($MN)
  • Table 51 Global Biomaterials Market Outlook, By Meshes (2021-2030) ($MN)
  • Table 52 Global Biomaterials Market Outlook, By Spine (2021-2030) ($MN)
  • Table 53 Global Biomaterials Market Outlook, By Spinal Fusion Surgeries (2021-2030) ($MN)
  • Table 54 Global Biomaterials Market Outlook, By Minimally Invasive Fusion Surgeries (2021-2030) ($MN)
  • Table 55 Global Biomaterials Market Outlook, By Motion Preservation & Dynamic Stabilization Surgeries (2021-2030) ($MN)
  • Table 56 Global Biomaterials Market Outlook, By Fracture Fixation Devices (2021-2030) ($MN)
  • Table 57 Global Biomaterials Market Outlook, By Bone Plates (2021-2030) ($MN)
  • Table 58 Global Biomaterials Market Outlook, By Screws (2021-2030) ($MN)
  • Table 59 Global Biomaterials Market Outlook, By Pins (2021-2030) ($MN)
  • Table 60 Global Biomaterials Market Outlook, By Rods (2021-2030) ($MN)
  • Table 61 Global Biomaterials Market Outlook, By Wires (2021-2030) ($MN)
  • Table 62 Global Biomaterials Market Outlook, By Synthetics Bone Grafts (2021-2030) ($MN)
  • Table 63 Global Biomaterials Market Outlook, By Ophthalmology (2021-2030) ($MN)
  • Table 64 Global Biomaterials Market Outlook, By Contact Lenses (2021-2030) ($MN)
  • Table 65 Global Biomaterials Market Outlook, By Intraocular Lenses (2021-2030) ($MN)
  • Table 66 Global Biomaterials Market Outlook, By Functional Replacement of Ocular Tissues (2021-2030) ($MN)
  • Table 67 Global Biomaterials Market Outlook, By Synthetic Corneas (2021-2030) ($MN)
  • Table 68 Global Biomaterials Market Outlook, By Dental (2021-2030) ($MN)
  • Table 69 Global Biomaterials Market Outlook, By Dental Implants (2021-2030) ($MN)
  • Table 70 Global Biomaterials Market Outlook, By Dental Bone Grafts & Substitutes (2021-2030) ($MN)
  • Table 71 Global Biomaterials Market Outlook, By Dental Membranes (2021-2030) ($MN)
  • Table 72 Global Biomaterials Market Outlook, By Tissue Regeneration (2021-2030) ($MN)
  • Table 73 Global Biomaterials Market Outlook, By Plastic Surgery (2021-2030) ($MN)
  • Table 74 Global Biomaterials Market Outlook, By Soft-Tissue Fillers (2021-2030) ($MN)
  • Table 75 Global Biomaterials Market Outlook, By Craniofacial Surgery (2021-2030) ($MN)
  • Table 76 Global Biomaterials Market Outlook, By Wound Healing (2021-2030) ($MN)
  • Table 77 Global Biomaterials Market Outlook, By Wound Closure Devices (2021-2030) ($MN)
  • Table 78 Global Biomaterials Market Outlook, By Surgical Hemostats (2021-2030) ($MN)
  • Table 79 Global Biomaterials Market Outlook, By Internal Tissue Sealants (2021-2030) ($MN)
  • Table 80 Global Biomaterials Market Outlook, By Adhesion Barriers (2021-2030) ($MN)
  • Table 81 Global Biomaterials Market Outlook, By Hernia Meshes (2021-2030) ($MN)
  • Table 82 Global Biomaterials Market Outlook, By Tissue Engineering (2021-2030) ($MN)
  • Table 83 Global Biomaterials Market Outlook, By Scaffolds for Regenerative Medicine (2021-2030) ($MN)
  • Table 84 Global Biomaterials Market Outlook, By Biosensing (2021-2030) ($MN)
  • Table 85 Global Biomaterials Market Outlook, By Tailoring of Inorganic Nanoparticles (2021-2030) ($MN)
  • Table 86 Global Biomaterials Market Outlook, By Neurological/Central Nervous System Applications (2021-2030) ($MN)
  • Table 87 Global Biomaterials Market Outlook, By Shunting Systems (2021-2030) ($MN)
  • Table 88 Global Biomaterials Market Outlook, By Cortical Neural Prosthetics (2021-2030) ($MN)
  • Table 89 Global Biomaterials Market Outlook, By Hydrogel Scaffolds for CNS Repair (2021-2030) ($MN)
  • Table 90 Global Biomaterials Market Outlook, By Neural Stem Cell Encapsulation (2021-2030) ($MN)
  • Table 91 Global Biomaterials Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 92 Global Biomaterials Market Outlook, By Drug Delivery Systems (2021-2030) ($MN)
  • Table 93 Global Biomaterials Market Outlook, By Gastrointestinal Applications (2021-2030) ($MN)
  • Table 94 Global Biomaterials Market Outlook, By Bariatric Surgery (2021-2030) ($MN)
  • Table 95 Global Biomaterials Market Outlook, By Urinary Applications (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.